| NOS1 inhibits the interferon response of cancer cells by S-nitrosylation of HDAC2 P Xu, S Ye, K Li, M Huang, Q Wang, S Zeng, X Chen, W Gao, J Chen, ... Journal of Experimental & Clinical Cancer Research 38, 1-16, 2019 | 41 | 2019 |
| Histone deacetylase 2 knockout suppresses immune escape of triple-negative breast cancer cells via downregulating PD-L1 expression P Xu, W Xiong, Y Lin, L Fan, H Pan, Y Li Cell death & disease 12 (8), 779, 2021 | 27 | 2021 |
| The role of S-nitrosylation of PFKM in regulation of glycolysis in ovarian cancer cells W Gao, M Huang, X Chen, J Chen, Z Zou, L Li, K Ji, Z Nie, B Yang, Z Wei, ... Cell death & disease 12 (4), 408, 2021 | 21 | 2021 |
| The heterocyclic compound Tempol inhibits the growth of cancer cells by interfering with glutamine metabolism S Ye, P Xu, M Huang, X Chen, S Zeng, Q Wang, J Chen, K Li, W Gao, ... Cell death & disease 11 (5), 312, 2020 | 20 | 2020 |
| Microcystins-LR induced apoptosis via S-nitrosylation of GAPDH in colorectal cancer cells K Li, M Huang, P Xu, M Wang, S Ye, Q Wang, S Zeng, X Chen, W Gao, ... Ecotoxicology and Environmental Safety 190, 110096, 2020 | 20 | 2020 |
| Mitochondrial NOS1 suppresses apoptosis in colon cancer cells through increasing SIRT3 activity Q Wang, S Ye, X Chen, P Xu, K Li, S Zeng, M Huang, W Gao, J Chen, ... Biochemical and biophysical research communications 515 (4), 517-523, 2019 | 19 | 2019 |
| The immunotherapy and immunosuppressive signaling in therapy-resistant prostate cancer P Xu, LJ Wasielewski, JC Yang, D Cai, CP Evans, WJ Murphy, C Liu Biomedicines 10 (8), 1778, 2022 | 14 | 2022 |
| Androgen receptor blockade resistance with enzalutamide in prostate cancer results in immunosuppressive alterations in the tumor immune microenvironment P Xu, JC Yang, B Chen, C Nip, JE Van Dyke, X Zhang, HW Chen, ... Journal for immunotherapy of cancer 11 (5), 2023 | 12 | 2023 |
| Novel inhibition of AKR1C3 and androgen receptor axis by PTUPB synergizes enzalutamide treatment in advanced prostate cancer JC Yang, P Xu, S Ning, LJ Wasielewski, H Adomat, SH Hwang, ... Oncogene 42 (9), 693-707, 2023 | 6 | 2023 |
| Inhibition of NOS1 promotes the interferon response of melanoma cells X Chen, Z Zou, Q Wang, W Gao, S Zeng, S Ye, P Xu, M Huang, K Li, ... Journal of translational medicine 20 (1), 205, 2022 | 5 | 2022 |
| 非清髓性单倍体骨髓移植后输注供体免疫细胞治疗白血病的研究 许鹏飞， 段连宁， 罗渊， 王喆， 陆承荣， 向培德， 雷英英 中国实验血液学杂志 3, 711-715, 2013 | 2 | 2013 |
| Allosteric inhibition of HSP70 in collaboration with STUB1 augments enzalutamide efficacy in antiandrogen resistant prostate tumor and patient-derived models P Xu, JC Yang, S Ning, B Chen, C Nip, Q Wei, L Liu, OT Johnson, AC Gao, ... Pharmacological research 189, 106692, 2023 | 1 | 2023 |
| Effect of the chemoprotectant tempol on anti-tumor activity of cisplatin S Ye, S Zeng, M Huang, J Chen, X Chen, P Xu, Q Wang, W Gao, B Yang, ... Nan fang yi ke da xue xue bao= Journal of Southern Medical University 39 (8 …, 2019 | 1 | 2019 |
| Plexin D1 emerges as a novel target in the development of neural lineage plasticity in treatment-resistant prostate cancer C Liu, B Chen, P Xu, J Yang, C Nip, L Wang, Y Shen, S Ning, Y Shang, ... | | 2024 |
| The role of PLXND1 in lineage plasticity and progression to neuroendocrine prostate cancer B Chen, P Xu, JC Yang, S Ning, L Wang, C Nip, AC Gao, C Liu Cancer Research 84 (6_Supplement), 3577-3577, 2024 | | 2024 |
| Dual targeting of HSP70 and AURKA improves treatment in neuroendocrine prostate cancer P Xu, JC Yang, B Chen, S Ning, L Wang, C Nip, CP Evans, MA Dall'Era, ... Cancer Research 84 (6_Supplement), 4567-4567, 2024 | | 2024 |
| 895 Immunosuppressive signaling is activated in enzalutamide resistant prostate cancer P Xu, JC Yang, B Chen, C Nip, L Wang, JEV Dyke, CP Evans, W Murphy, ... Journal for ImmunoTherapy of Cancer 11 (Suppl 1), 2023 | | 2023 |
| Enzalutamide resistance results in immunosuppressive alterations in prostate tumor immune microenvironment P Xu, JC Yang, B Chen, C Nip, JE Van Dyke, CP Evans, WJ Murphy, ... Cancer Research 83 (7_Supplement), 5151-5151, 2023 | | 2023 |
| MP20-11 ENZALUTAMIDE RESISTANCE RESULTS IN IMMUNOSUPPRESSIVE ALTERATIONS IN PROSTATE TUMOR IMMUNE MICROENVIRONMENT P Xu, JC Yang, B Chen, C Nip, JE Van Dyke, CP Evans, WJ Murphy, ... The Journal of Urology 209 (Supplement 4), e279, 2023 | | 2023 |
| PD04-09 COMBINATION TREATMENT WITH HSP70/STUB1 MODULATOR AND ENZALUTAMIDE YIELDS SYNERGISTIC ACTIVITY IN ADVANCED PROSTATE CANCER P Xu, JC Yang, B Chen, C Nip, S Ning, AC Gao, H Shao, J Gestwicki, ... The Journal of Urology 209 (Supplement 4), e145, 2023 | | 2023 |
